Guangzhou Excelmab Inc.
1 clinical trials · Sponsor
◉ Watch Guangzhou Excelmab Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma (NCT06021678) | Guangzhou Excelmab Inc. | 2021-11-12 |
Track Guangzhou Excelmab Inc. automatically
Every clearance here is in the API, with alerts when new ones post.